SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/C0E93F56B2822558B55FF7766340BA39CCB0FCEC8AFE057C47020D6D95DFB69273FB9F166E5C529B293B88F94099A820>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/C0E93F56B2822558B55FF7766340BA39CCB0FCEC8AFE057C47020D6D95DFB69273FB9F166E5C529B293B88F94099A820
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/C0E93F56B2822558B55FF7766340BA39CCB0FCEC8AFE057C47020D6D95DFB69273FB9F166E5C529B293B88F94099A820
http://www.w3.org/2000/01/rdf-schema#comment
"These results demonstrate that the activities of AR and mTOR pathways are maintained by KLK4 which may thus be a viable target for therapy"
xsd:string
http://purl.uniprot.org/uniprot/#_879CA3C5DCE0F5B6328309494EEB8DFC2EAA26FC014C846146455D53DBCD2A5F98D0C3B7D3EFD4B04EFF3ADA6D08522B
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/C0E93F56B2822558B55FF7766340BA39CCB0FCEC8AFE057C47020D6D95DFB69273FB9F166E5C529B293B88F94099A820
http://purl.uniprot.org/uniprot/Q96JD9
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C0E93F56B2822558B55FF7766340BA39CCB0FCEC8AFE057C47020D6D95DFB69273FB9F166E5C529B293B88F94099A820
http://purl.uniprot.org/uniprot/#_Q96JD9-mappedCitation-23798432
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C0E93F56B2822558B55FF7766340BA39CCB0FCEC8AFE057C47020D6D95DFB69273FB9F166E5C529B293B88F94099A820